BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to invest in. On November 13, BMO Capital initiated coverage of BrightSpring Health with an Outperform rating and $40 ...

We may receive a commission on purchases made from links. Most people are no longer used to receiving snail mail because of the convenience email, instant messaging, and many apps offer. And even ...

Microsoft is investigating an Exchange Online service outage that is preventing customers from accessing their mailboxes using the classic Outlook desktop client. Microsoft first acknowledged the ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

(NEXSTAR) — Tuesday, November 11, will carry two points of significance this year, one of which will save you a trip to the mailbox. That is, of course, because Tuesday is Veterans Day, when Americans ...

(RTTNews) - Swiss drug major Novartis AG (NVS) reported Tuesday higher net income in its third quarter, benefited by sales growth above market estimates. Looking ahead for fiscal 2025, the company ...

Outlook won’t simply bolt on AI but rebuild around it. Outlook won’t simply bolt on AI but rebuild around it. is a senior editor and author of Notepad, who has been covering all things Microsoft, PC, ...

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...

Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups aligned with the Trump ...

I’ve tried just about every form of artificial intelligence there is on offer to consumers, from AI companions down to video generation software. I’ve been sure to give a range of different tools a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. For the first time, a generic GLP-1 has been approved by ...